1	Pfizer	pfizer	NNP	p2=NN	2	nsubj	2:A0=PAG
2	raises	raise	VBZ	pb=raise.01	0	root	_
3	the	the	DT	_	4	det	_
4	stakes	stake	NNS	_	2	dobj	2:A1=PPT
5	â€	â€	POS	p2=,	4	possessive	_
6	"	"	''	p2=``	2	punct	_
7	and	and	CC	_	4	cc	_
8	some	some	DT	_	9	det	_
9	eyebrows	eyebrow	NNS	_	4	conj	_
10	â€	â€	,	p2=POS	2	punct	_
11	"	"	''	p2=``	2	punct	_
12	in	in	IN	_	2	prep	2:AM-MNR
13	its	its	PRP$	_	14	poss	_
14	offer	offer	NN	_	12	pobj	_
15	for	for	IN	_	14	prep	_
16	AstraZeneca	astrazeneca	NNP	_	15	pobj	_
17	.	.	.	_	2	punct	_

1	Pfizer	pfizer	NNP	p2=NN	2	nsubj	2:A0=PAG;15:A0=PAG
2	made	make	VBD	pb=make.01	0	root	_
3	what	what	WP	_	6	dobj	6:R-A2
4	it	it	PRP	_	6	nsubj	6:A0=PAG
5	's	's	VBZ	_	6	aux	_
6	calling	call	VBG	pb=call.01	2	ccomp	2:A1=PRD
7	its	its	PRP$	_	11	poss	_
8	fourth	#ord#	JJ	_	11	amod	_
9	and	and	CC	_	8	cc	_
10	final	final	JJ	_	8	conj	_
11	offer	offer	NN	_	6	dobj	6:A1=PPT
12	for	for	IN	_	11	prep	_
13	AstraZeneca	astrazeneca	NNP	_	12	pobj	_
14	,	,	,	_	2	punct	_
15	submitting	submit	VBG	pb=submit.01	2	advcl	2:AM-ADV
16	a	a	DT	_	17	det	_
17	proposal	proposal	NN	_	15	dobj	15:A1=PPT
18	to	to	TO	_	19	aux	_
19	buy	buy	VB	pb=buy.01	17	infmod	_
20	the	the	DT	_	21	det	_
21	company	company	NN	_	19	dobj	19:A1=PPT
22	for	for	IN	_	19	prep	19:A3=VSP
23	$	$	$	_	25	quantmod	_
24	117	0	CD	_	25	number	_
25	billion	#crd#	CD	_	26	nn	_
26	â€	â€	NNS	p2=,	22	pobj	_
27	"	"	''	p2=``	26	punct	_
28	after	after	IN	p2=RB	15	prep	15:AM-TMP
29	previously	previously	RB	_	30	advmod	30:AM-TMP
30	bidding	bid	VBG	pb=bid.01	28	pcomp	_
31	$	$	$	_	33	quantmod	_
32	106	0	CD	_	33	number	_
33	billion	#crd#	CD	_	30	dobj	30:A1=PPT
34	on	on	IN	_	30	prep	30:AM-TMP
35	May	may	NNP	_	34	pobj	_
36	2	0	CD	_	35	num	_
37	.	.	.	_	2	punct	_

1	The	the	DT	_	3	det	_
2	latest	late	JJS	_	3	amod	_
3	proposal	proposal	NN	_	4	nsubj	4:A0=PAG
4	increases	increase	VBZ	pb=increase.01	0	root	_
5	the	the	DT	_	7	det	_
6	cash	cash	NN	_	7	nn	_
7	component	component	NN	_	4	dobj	4:A1=PPT
8	of	of	IN	_	7	prep	_
9	the	the	DT	_	10	det	_
10	offer	offer	NN	_	8	pobj	_
11	to	to	IN	p2=TO	4	prep	4:A4=GOL
12	45	0	CD	_	13	num	_
13	percent	percent	NN	_	11	pobj	_
14	from	from	IN	_	4	prep	4:A3=DIR
15	33	0	CD	_	16	num	_
16	percent	percent	NN	_	14	pobj	_
17	.	.	.	_	4	punct	_

1	In	in	IN	_	10	prep	10:AM-DIS
2	addition	addition	NN	_	1	pobj	_
3	,	,	,	_	10	punct	_
4	Pfizer	pfizer	NNP	_	10	nsubj	10:A0
5	(	(	-LRB-	_	6	punct	_
6	NYSE	nyse	NNP	p2=NN	4	appos	_
7	:	:	:	_	6	punct	_
8	PFE	pfe	NNP	p2=NN	6	appos	_
9	)	)	-RRB-	_	6	punct	_
10	said	say	VBD	pb=say.01	0	root	_
11	it	it	PRP	_	14	nsubj	14:A0=PAG
12	will	will	MD	_	14	aux	14:AM-MOD
13	not	not	RB	_	14	neg	14:AM-NEG
14	make	make	VB	pb=make.02	10	ccomp	10:A1=PPT
15	a	a	DT	_	17	det	_
16	hostile	hostile	JJ	_	17	amod	_
17	offer	offer	NN	_	14	dobj	14:AM-PRR
18	directly	directly	RB	_	14	advmod	14:AM-MNR
19	to	to	IN	_	14	prep	14:A1=PRD
20	AstraZeneca	astrazeneca	NNP	_	19	pobj	_
21	(	(	-LRB-	_	14	punct	_
22	NYSE	nyse	NNP	p2=NN	26	nn	_
23	:	:	:	_	22	punct	_
24	AZN	azn	NNP	p2=NN	22	appos	_
25	)	)	-RRB-	_	24	punct	_
26	shareholders	shareholder	NNS	_	14	dobj	_
27	,	,	,	_	14	punct	_
28	meaning	mean	VBG	pb=mean.01	14	advcl	14:AM-ADV
29	it	it	PRP	_	32	nsubj	32:A0=PAG
30	will	will	MD	_	32	aux	32:AM-MOD
31	only	only	RB	_	32	advmod	32:AM-ADV
32	proceed	proceed	VB	pb=proceed.01	28	ccomp	28:A1=PPT
33	with	with	IN	_	32	prep	32:A1=PPT
34	a	a	DT	_	35	det	_
35	deal	deal	NN	_	33	pobj	_
36	if	if	IN	_	38	mark	_
37	it	it	PRP	_	38	nsubj	38:A0=PAG
38	gets	get	VBZ	pb=get.01	32	advcl	_
39	the	the	DT	_	40	det	_
40	recommendation	recommendation	NN	_	38	dobj	38:A1=PPT
41	of	of	IN	_	40	prep	_
42	AstraZenecaâ€™s	astrazenecaâ€™s	NNP	p2=JJ	43	nn	_
43	board	board	NN	_	41	pobj	_
44	.	.	.	_	10	punct	_

1	Pfizerâ€™s	pfizerâ€™s	NNS	p2=VBZ	2	nsubj	2:A0=PAG;4:A0=PAG;8:A2=GOL
2	plan	plan	VBP	pb=plan.01	0	root	_
3	to	to	TO	_	4	aux	_
4	merge	merge	VB	pb=merge.01	2	xcomp	2:A1=PPT
5	with	with	IN	_	4	prep	4:A2=PPT
6	AstraZeneca	astrazeneca	NNP	_	5	pobj	_
7	would	would	MD	_	8	aux	8:AM-MOD
8	include	include	VB	pb=include.01	2	conj	_
9	putting	put	VBG	pb=put.01	8	xcomp	8:A1=PPT
10	the	the	DT	_	12	det	_
11	combined	combine	VBN	p2=JJ|pb=combine.01	12	amod	_
12	company	company	NN	_	14	poss	11:A1=PPT
13	's	's	POS	_	12	possessive	_
14	headquarters	headquarters	NN	p2=NNS	9	dobj	9:A1=PPT
15	in	in	IN	_	9	prep	9:A2=GOL
16	London	london	NNP	_	15	pobj	_
17	to	to	TO	_	18	aux	_
18	take	take	VB	pb=take.01	9	advcl	9:AM-PRP
19	advantage	advantage	NN	_	18	dobj	18:A1=PPT
20	of	of	IN	_	18	prep	18:A2=DIR
21	substantial	substantial	JJ	_	23	amod	_
22	tax	tax	NN	_	23	nn	_
23	savings	saving	NNS	_	20	pobj	_
24	.	.	.	_	2	punct	_

1	A	a	DT	_	2	det	_
2	deal	deal	NN	_	5	nsubj	5:A0=PAG
3	would	would	MD	_	5	aux	5:AM-MOD
4	also	also	RB	_	5	advmod	5:AM-DIS
5	bolster	bolster	VB	pb=bolster.01	0	root	_
6	Pfizerâ€™s	pfizerâ€™s	NNP	p2=JJ	7	nn	_
7	pipeline	pipeline	NN	_	5	dobj	5:A1=PPT
8	of	of	IN	_	7	prep	_
9	new	new	JJ	_	11	amod	_
10	drug	drug	NN	_	11	nn	_
11	candidates	candidate	NNS	_	8	pobj	_
12	,	,	,	_	7	punct	_
13	particularly	particularly	RB	_	15	advmod	_
14	new	new	JJ	_	15	amod	_
15	therapies	therapy	NNS	_	7	appos	_
16	for	for	IN	_	15	prep	_
17	treating	treat	VBG	pb=treat.03	16	pcomp	_
18	cancer	cancer	NN	_	17	dobj	17:A1=PPT
19	,	,	,	_	17	punct	_
20	at	at	IN	_	17	prep	17:AM-TMP
21	a	a	DT	_	22	det	_
22	time	time	NN	_	20	pobj	26:AM-TMP
23	when	when	WRB	_	26	advmod	26:R-AM-TMP
24	Pfizer	pfizer	NNP	p2=NN	26	nsubj	26:A0=PAG
25	is	be	VBZ	_	26	aux	_
26	dealing	deal	VBG	pb=deal.01	22	rcmod	_
27	with	with	IN	_	26	prep	26:A1=PPT
28	generic	generic	JJ	_	29	amod	_
29	competition	competition	NN	_	27	pobj	_
30	for	for	IN	_	29	prep	_
31	Lipitor	lipitor	NNP	p2=NN	30	pobj	_
32	and	and	CC	_	29	cc	_
33	the	the	DT	_	35	det	_
34	looming	loom	VBG	p2=JJ|pb=loom.01	35	amod	_
35	loss	loss	NN	_	29	conj	34:A1=PAG
36	of	of	IN	_	35	prep	_
37	patent	patent	NN	_	38	nn	_
38	protection	protection	NN	_	36	pobj	_
39	for	for	IN	_	35	prep	_
40	Viagra	viagra	NNP	_	39	pobj	_
41	.	.	.	_	5	punct	_

1	The	the	DT	_	3	det	_
2	two	#crd#	CD	_	3	num	_
3	companies	company	NNS	_	4	nsubj	4:A0=PAG
4	have	have	VBP	pb=have.03	0	root	_
5	strong	strong	JJ	_	6	amod	_
6	ties	tie	NNS	_	4	dobj	4:A1=PPT
7	to	to	IN	_	6	prep	_
8	the	the	DT	_	10	det	_
9	local	local	JJ	_	10	amod	_
10	region	region	NN	_	7	pobj	_
11	.	.	.	_	4	punct	_

1	AstraZeneca	astrazeneca	NNP	_	7	nsubj	7:A0=PAG;3:A1=PPT
2	,	,	,	_	1	punct	_
3	based	base	VBN	pb=base.01	1	partmod	_
4	in	in	IN	_	3	prep	3:AM-LOC
5	London	london	NNP	_	4	pobj	_
6	,	,	,	_	1	punct	_
7	has	have	VBZ	pb=have.03	0	root	_
8	its	its	PRP$	_	10	poss	_
9	U.S.	u.s.	NNP	_	10	nn	_
10	headquarters	headquarters	NN	p2=NNS	7	dobj	7:A1=PPT
11	in	in	IN	_	10	prep	_
12	Wilmington	wilmington	NNP	_	11	pobj	_
13	,	,	,	_	12	punct	_
14	Del	del	NNP	_	12	appos	_
15	.	.	.	_	7	punct	_

1	Pfizer	pfizer	NNP	p2=NN	8	nsubj	8:A0=PAG;3:A1=PPT
2	,	,	,	_	1	punct	_
3	based	base	VBN	pb=base.01	1	partmod	_
4	in	in	IN	_	3	prep	3:AM-LOC
5	New	new	NNP	_	6	nn	_
6	York	york	NNP	_	4	pobj	_
7	,	,	,	_	1	punct	_
8	has	have	VBZ	pb=have.03	0	root	_
9	operations	operation	NNS	_	8	dobj	8:A1=PPT
10	in	in	IN	_	9	prep	_
11	Collegeville	collegeville	NNP	_	10	pobj	_
12	,	,	,	_	11	punct	_
13	Pa	pa	NNP	_	11	appos	_
14	.	.	.	_	8	punct	_

1	Elected	elect	VBN	pb=elect.01	2	amod	_
2	officials	official	NNS	_	6	nsubj	6:A0=PAG;1:A2=PRD
3	in	in	IN	_	2	prep	_
4	Delaware	delaware	NNP	_	3	pobj	_
5	have	have	VBP	_	6	aux	_
6	expressed	express	VBN	pb=express.01	0	root	_
7	concerns	concern	NNS	_	6	dobj	6:A1=PPT
8	about	about	IN	_	7	prep	_
9	job	job	NN	_	10	nn	_
10	losses	loss	NNS	_	8	pobj	_
11	in	in	IN	_	10	prep	_
12	their	their	PRP$	_	13	poss	_
13	state	state	NN	_	11	pobj	_
14	should	should	MD	_	17	aux	17:AM-MOD
15	the	the	DT	_	16	det	_
16	merger	merger	NN	_	17	nsubj	17:A1=PPT
17	happen	happen	VB	pb=happen.01	6	ccomp	_
18	.	.	.	_	6	punct	_

1	Ian	ian	NNP	_	2	nn	_
2	Read	read	NNP	_	15	nsubj	15:A0
3	,	,	,	_	2	punct	_
4	chairman	chairman	NN	_	2	appos	_
5	and	and	CC	_	4	cc	_
6	CEO	ceo	NN	_	4	conj	_
7	of	of	IN	_	4	prep	_
8	Pizer	pizer	NNP	p2=NN	7	pobj	_
9	,	,	,	_	2	punct	_
10	in	in	IN	_	15	prep	15:AM-LOC
11	a	a	DT	_	13	det	_
12	prepared	prepared	JJ	p2=VBN	13	amod	_
13	statement	statement	NN	_	10	pobj	_
14	,	,	,	_	15	punct	_
15	said	say	VBD	pb=say.01	0	root	_
16	he	he	PRP	_	17	nsubj	17:A0=PAG
17	believes	believe	VBZ	pb=believe.01	15	ccomp	15:A1=PPT
18	the	the	DT	_	20	det	_
19	revised	revise	VBN	p2=JJ|pb=revise.01	20	amod	_
20	offer	offer	NN	_	22	nsubjpass	19:A1=PPT;22:A1
21	is	be	VBZ	_	22	auxpass	_
22	â€œcompellingâ€�	â€œcompellingâ€�	VBN	p2=,|pb=â€œcompellingâ€�.01	17	ccomp	17:A1=PPT
23	for	for	IN	_	22	prep	22:A2
24	AstraZeneca	astrazeneca	NNP	_	26	poss	_
25	's	's	POS	_	24	possessive	_
26	shareholders	shareholder	NNS	_	23	pobj	_
27	and	and	CC	_	23	cc	_
28	that	that	IN	_	23	conj	_
29	a	a	DT	_	33	det	_
30	Pfizer	pfizer	NNP	p2=NN	32	hmod	_
31	-	-	HYPH	_	32	hyph	_
32	AstraZeneca	astrazeneca	NNP	_	33	nn	_
33	combination	combination	NN	_	20	appos	_
34	â€œis	â€œis	''	p2=NNS	33	punct	_
35	in	in	IN	_	33	prep	_
36	the	the	DT	_	38	det	_
37	best	good	JJS	p2=RBS	38	amod	_
38	interestsâ€�	interestsâ€�	NNS	p2=NN	35	pobj	_
39	of	of	IN	_	38	prep	_
40	all	all	DT	_	41	det	_
41	stakeholders	stakeholder	NNS	_	39	pobj	_
42	.	.	.	_	15	punct	_

1	If	if	IN	_	4	mark	_
2	you	you	PRP	_	4	nsubj	4:A0=PAG;5:A0=PAG
3	are	be	VBP	_	4	aux	_
4	commenting	comment	VBG	pb=comment.01	15	advcl	15:AM-ADV
5	using	use	VBG	pb=use.01	4	xcomp	4:A1=PPT
6	a	a	DT	_	8	det	_
7	Facebook	facebook	NNP	p2=NN	8	nn	_
8	account	account	NN	_	5	dobj	5:A1=PPT
9	,	,	,	_	15	punct	_
10	your	your	PRP$	_	12	poss	_
11	profile	profile	NN	p2=JJ	12	nn	_
12	information	information	NN	_	15	nsubjpass	15:A1=PPT
13	may	may	MD	_	15	aux	15:AM-MOD
14	be	be	VB	_	15	auxpass	_
15	displayed	display	VBN	pb=display.01	0	root	_
16	with	with	IN	_	15	prep	15:A2=LOC
17	your	your	PRP$	_	18	poss	_
18	comment	comment	NN	_	16	pobj	19:A0=PAG
19	depending	depend	VBG	pb=depend.01	18	partmod	_
20	on	on	IN	_	19	prep	19:A1=PPT
21	your	your	PRP$	_	23	poss	_
22	privacy	privacy	NN	_	23	nn	_
23	settings	setting	NNS	_	20	pobj	_
24	.	.	.	_	15	punct	_

1	By	by	IN	_	16	prep	16:AM-MNR
2	leaving	leave	VBG	pb=leave.01	1	pcomp	_
3	the	the	DT	_	5	det	_
4	'	'	``	p2=''	5	punct	_
5	Post	post	NNP	p2=JJ	2	dobj	2:A1=DIR
6	to	to	IN	p2=TO	2	prep	2:A2=PRD
7	Facebook	facebook	NNP	_	9	poss	_
8	'	'	POS	p2=''	7	possessive	_
9	box	box	NN	_	6	pobj	10:A1=PPT
10	selected	select	VBD	p2=VBN|pb=select.01	9	partmod	_
11	,	,	,	_	16	punct	_
12	your	your	PRP$	_	13	poss	_
13	comment	comment	NN	_	16	nsubjpass	16:A1=PRD
14	will	will	MD	_	16	aux	16:AM-MOD
15	be	be	VB	_	16	auxpass	_
16	published	publish	VBN	pb=publish.01	0	root	_
17	to	to	IN	_	16	prep	16:AM-GOL
18	your	your	PRP$	_	20	poss	_
19	Facebook	facebook	NNP	p2=NN	20	nn	_
20	profile	profile	NN	p2=VB	17	pobj	_
21	in	in	IN	_	16	prep	16:AM-LOC
22	addition	addition	NN	_	21	pobj	_
23	to	to	IN	_	22	prep	_
24	the	the	DT	_	25	det	_
25	space	space	NN	_	23	pobj	_
26	below	below	RB	_	25	advmod	_
27	.	.	.	_	16	punct	_

1	Sign	sign	VB	p2=VBN|pb=sign.03	0	root	_
2	up	up	RP	p2=IN	1	prt	1:C-V
3	to	to	TO	_	4	aux	_
4	receive	receive	VB	pb=receive.01	1	advcl	1:AM-PRP
5	Philadelphia	philadelphia	NNP	_	6	nn	_
6	Business	business	NNP	p2=NN	7	nn	_
7	Journal	journal	NNP	_	10	poss	_
8	's	's	POS	_	7	possessive	_
9	Morning	morning	NNP	_	10	nn	_
10	Edition	edition	NNP	_	4	dobj	4:A1=PPT
11	and	and	CC	_	10	cc	_
12	Afternoon	afternoon	NNP	_	13	nn	_
13	Edition	edition	NNP	_	10	conj	_
14	newsletters	newsletter	NNS	_	10	appos	_
15	and	and	CC	_	1	cc	_
16	breaking	break	VBG	pb=break.01	1	conj	_
17	news	news	NN	_	18	nn	_
18	alerts	alert	NNS	_	16	dobj	16:A1=PPT
19	.	.	.	_	1	punct	_

